Idrabiotaparinux sodium
- Generic Name
- Idrabiotaparinux sodium
Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation
- Conditions
- Atrial Fibrillation
- Interventions
- Drug: Placebo (for warfarin)Drug: Placebo (for idrabiotaparinux)Drug: Placebo (for avidin)
- First Posted Date
- 2007-12-24
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 3773
- Registration Number
- NCT00580216
- Locations
- ๐บ๐ธ
Sanofi-Aventis Investigational Site Number 840128, Philadelphia, Pennsylvania, United States
๐บ๐ธSanofi-Aventis Investigational Site Number 840181, Pittsburgh, Pennsylvania, United States
๐บ๐ธSanofi-Aventis Investigational Site Number 840146, Cleveland, Ohio, United States
Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach
- Conditions
- ThrombosisEmbolism
- Interventions
- Drug: Placebo (for idrabiotaparinux sodium)Drug: Placebo (for warfarin)
- First Posted Date
- 2006-06-28
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 3202
- Registration Number
- NCT00345618
- Locations
- ๐ท๐บ
Sanofi-Aventis Admnistrative Office, Moscow, Russian Federation
๐ฌ๐งSanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom
๐ฆ๐บsanofi-aventis Australia & New Zealand administrative office, Macquarie Park, New South Wales, Australia
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
- Conditions
- Deep Venous Thrombosis
- Interventions
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 757
- Registration Number
- NCT00311090
- Locations
- ๐ท๐บ
Sanofi-aventis, Moscow, Russian Federation
๐ฒ๐ฝsanofi-aventis Mexico, Mexico, Mexico
๐น๐ทsanofi-aventis Turkey, Istanbul, Turkey
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.